Company Announcements Harfordbusiness.com reported in January that Eppendorf is undertaking a $25 million, 130,000-sq-ft expansion of its Enfield, Connecticut, production plant, which makes pipettes and pipette tips. The company expects to add 75–90 workers as a result of the expansion. Sartorius named Dominique Baly to the newly created position of president of Sartorius Group Laboratory […]
Despite market volatility caused by upheaval in the Middle East, soaring crude oil prices and disappointing GDP estimates, in February, the Dow Jones Industrial Average and S&P 500 climbed 2.8% each, and the NASDAQ improved 3.0%. On February 25, the fourth-quarter GDP growth estimate was revised down to 2.8% from 3.2%, well below analysts’ forecast […]
Calendar-year 2010 ended strongly as companies reported good growth in both industrial and life science end-markets in the calendar-year fourth quarter. Companies were also optimistic about 2011 growth prospects. For the eight businesses whose financial results are presented on pages 9–11, calendar-year fourth-quarter 2010 revenues increased 11.8%, or 7.2% organically. Illumina and Agilent Life Sciences […]
The US government enacted the $787 billion American Recovery and Reinvestment Act (ARRA) in early 2009. The ARRA provided $21.5 billion for R&D (see IBO 2/28/09). ARRA funding was required to be obligated by September 30, 2010, the end of the federal government’s fiscal year 2010. Although ARRA obligations have been completed, ARRA spending has […]
Japan’s total R&D expenditures declined for the second year in a row in fiscal 2010 (April 1, 2009–March 31, 2010). The country’s total R&D expenditures reached ¥17,246.3 billion ($185.4 billion = ¥93 = $1), a decrease of 8.3%. Total R&D expenditures as a percentage of GDP declined 0.18% to 3.62% in fiscal 2010. The figures […]
Thirteen of the 20 companies in the IBO Laboratory Sales Index reported fourth-quarter earnings before this issue’s publication. OI was removed following the acquisition by ITT in November (see IBO 9/15/10). Based on estimates for companies yet to report, fourth-quarter revenue for the Index improved 6.2%, including a loss of 0.2% from currency, to $5,912.9 […]
Japan’s total R&D expenditures declined for the second year in a row in fiscal 2010 (April 1, 2009–March 31, 2010). The country’s total R&D expenditures reached ¥17,246.3 billion ($185.4 billion = ¥93 = $1), a decrease of 8.3%. Total R&D expenditures as a percentage of GDP declined 0.18% to 3.62% in fiscal 2010. The figures […]
South San Francisco, CA 2/10/11—Microfluidics company Fluidigm has completed its IPO (see IBO 12/15/10), offering 5,558,333 shares of common stock at a public price of $13.50 per share. Last month, Fluidigm announced that pricing would be $13.50–$15.50 (see IBO 1/31/11). The underwriters have been granted a right to purchase up to an additional 833,750 shares […]
Washington, DC 1/20/11; Washington, DC 1/28/11—Fluidigm has announced in a filing with the SEC that it will offer 5.17 million shares of its common stock in its IPO (see IBO 12/15/10). The IPO price will be $13.50–$15.50 per share. Based on an offering price of $14.50, the company estimates raising $68.3 million, of which $15 […]
Shenzhen, China 1/25/11—Jiangsu Skyray Instruments, a supplier of atomic spectroscopy, molecular spectroscopy and GC systems, has completed an IPO on the Shenzhen stock exchange’s ChiNext market. According to the Shenzhen stock exchange, the company issued 18.5 million shares priced at CNY 65 ($9.86 = CNY 6.57 = $1) per share, with 14.8 million shares listed […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
